Jefferies analyst Brian Tanquilut has maintained their bullish stance on RDNT stock, giving a Buy rating today.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Brian Tanquilut has given his Buy rating due to a combination of factors, primarily centered around RadNet’s strategic acquisition of See-Mode Technologies. This acquisition is seen as a significant enhancement to RadNet’s AI capabilities, particularly in the ultrasound sector, which is expected to expand the company’s operational capacity and revenue potential substantially.
See-Mode’s FDA-approved AI technology is anticipated to improve the efficiency of RadNet’s ultrasound operations by reducing scan times, thus increasing the throughput of their existing equipment. This operational improvement is projected to generate an additional $80 million in revenue without necessitating further capital expenditure. Furthermore, Tanquilut acknowledges that while some investors prefer clinic acquisitions, the disciplined approach of RadNet’s management in pursuing AI deals is strategically sound and financially promising, with the potential for considerable revenue and EBITDA growth.
Tanquilut covers the Healthcare sector, focusing on stocks such as Brookdale Senior Living, Radnet, and Addus Homecare. According to TipRanks, Tanquilut has an average return of 3.9% and a 51.57% success rate on recommended stocks.